You are here

Prevenar Special Use-result Surveillance in Japan (Regulatory PostMarketing Commitment Plan)

Last updated on March 15, 2019

FOR MORE INFORMATION
Study Location
Yokoyama Children's Clinic
Kasuga, Fukuoka, 816-0801 Japan
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Pneumococcal Vaccine, Streptococcus Pneumoniae
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
2 + months
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Infants at the age of more than 2 and less than 7 months

- Infants who have been vaccinated with Prevenar for the first time

- Infants expected to complete four vaccinations with Prevenar

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

Vaccination with Prevenar must not be given to any of the following;

- History of evident anaphylactic reaction to any component of Prevenar or diphtheria
toxoid

- Evident pyrexia

- Evident serious acute disease

- Any other infants or children ineligible for vaccination

NCT01521897
Pfizer
Completed
Prevenar Special Use-result Surveillance in Japan (Regulatory PostMarketing Commitment Plan)

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now